Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial
Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial
Teresa Lambe, Abigail Platt, Helen Sanders, Tanya Dinesh et al.
Citations
4 citations
Journal
The Lancet Microbe
Topics
Viral Infections and Outbreaks Research
Field-Weighted Citation Impact (FWCI)
5.58
article
Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial
Teresa Lambe, Abigail Platt, Helen Sanders, Tanya Dinesh, Eleanor Berrie, Paola Cicconi, Alison M. Lawrie, Ian Poulton, Daniel Jenkin, Rebecca Makinson, Nguyen Tran, Alex Sampson, Reece Mabbett, Jack Quaddy
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet MicrobeVol. 6(5)
Institutions
University of Oxford (GB), Science Oxford (GB), Jenner Institute (GB)